Changes in levels of sphingolipids, particularly of glycosphingolipids, were recently described in the central nervous system of ALS patients at disease endpoint and in SOD1 mice at various disease stages13, 14. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.